Authors

• Carine Wouters
• Michel Moutschen (ORCID: https://orcid.org/0000-0002-6405-1785)
• Vito Sabato (ORCID: https://orcid.org/0000-0002-1321-314X)
• Joke Dehoorne (ORCID: https://orcid.org/0000-0003-4759-0717)
• Cécile Boulanger (ORCID: https://orcid.org/0000-0002-2969-6131)
• Florence Roufosse (ORCID: https://orcid.org/0000-0002-5288-0375)
• Jeroen C.H. van der Hilst (ORCID: https://orcid.org/0000-0003-4527-6310)
• Hilde Rabijns (ORCID: https://orcid.org/0009-0007-5504-3293)
• Eléonore Maury (ORCID: https://orcid.org/0000-0001-7517-1988)
• Rik Joos (ORCID: https://orcid.org/0000-0002-6087-3861)
• Marijn Witterzeel

Institutions

• Cliniques Universitaires Saint-Luc (BE)
• Université Libre de Bruxelles (BE)
• University of Antwerp (BE)
• University of Liège (BE)
• Ghent University Hospital (BE)
• Jessa Hospital (BE)
• Centre Hospitalier Universitaire de Liège (BE)
• Novartis (Belgium) (BE)
• Ziekenhuisnetwerk Antwerpen Stuivenberg (BE)
• Hasselt University (BE)
• KU Leuven (BE)

Publication Details

Journal

BMC Rheumatology

Published

2025-05-29

DOI

https://doi.org/10.1186/s41927-025-00515-w

Citations

1

Primary Topic

Autoimmune and Inflammatory Disorders Research

Type

article

Field-Weighted Citation Impact

1.77

Funders

• Novartis Pharma